BioLineRx Balance Sheet Health
Financial Health criteria checks 5/6
BioLineRx has a total shareholder equity of $13.2M and total debt of $9.8M, which brings its debt-to-equity ratio to 73.9%. Its total assets and total liabilities are $63.9M and $50.7M respectively.
Key information
73.9%
Debt to equity ratio
US$9.77m
Debt
| Interest coverage ratio | n/a |
| Cash | US$42.99m |
| Equity | US$13.22m |
| Total liabilities | US$50.70m |
| Total assets | US$63.93m |
Recent financial health updates
Does BioLineRx (TLV:BLRX) Have A Healthy Balance Sheet?
Apr 02
BioLineRx (TLV:BLRX) Has Debt But No Earnings; Should You Worry?
Aug 25Health Check: How Prudently Does BioLineRx (TLV:BLRX) Use Debt?
Apr 05Is BioLineRx (TLV:BLRX) A Risky Investment?
Jun 17Is BioLineRx (TLV:BLRX) Using Debt In A Risky Way?
Feb 26Recent updates
Does BioLineRx (TLV:BLRX) Have A Healthy Balance Sheet?
Apr 02BioLineRx (TLV:BLRX) Has Debt But No Earnings; Should You Worry?
Aug 25Health Check: How Prudently Does BioLineRx (TLV:BLRX) Use Debt?
Apr 05Is BioLineRx (TLV:BLRX) A Risky Investment?
Jun 17Is BioLineRx (TLV:BLRX) Using Debt In A Risky Way?
Feb 26Is BioLineRx (TLV:BLRX) Using Debt In A Risky Way?
Oct 17Financial Position Analysis
Short Term Liabilities: BLRX's short term assets ($47.2M) exceed its short term liabilities ($30.9M).
Long Term Liabilities: BLRX's short term assets ($47.2M) exceed its long term liabilities ($19.9M).
Debt to Equity History and Analysis
Debt Level: BLRX has more cash than its total debt.
Reducing Debt: BLRX's debt to equity ratio has increased from 21.1% to 73.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BLRX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BLRX has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 0.4% each year.